TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23106253

Group type: EXPERIMENTAL
Intervention: Increased TpTe/QT ratio (0.24 ± 0.03 ms)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Increased TpTe (105.56 ± 20.36 ms)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Increased TpTe/QT ratio (0.22 ± 0.04)
Number of subjects: 128

Group type: COMPARATOR
Intervention: QT interval
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: TpTe/QT ratio ≥ 0.25
Number of subjects: 128
Study: 21723750

Group type: EXPERIMENTAL
Intervention: WF10 (Immunokine)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19186971

Group type: EXPERIMENTAL
Intervention: Submerged implants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-submerged implants
Number of subjects: 0
Study: 17075109

Group type: EXPERIMENTAL
Intervention: Palifermin (40 microg/kg for 3 consecutive days)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Palifermin
Number of subjects: 64

Group type: COMPARATOR
Intervention: Palifermin and Placebo
Number of subjects: 64
Study: 14970775

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3% mepivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical anesthetic gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 40
Study: 11360129

Group type: EXPERIMENTAL
Intervention: Beta-carotene (42 mg)
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Vitamin A (7000 microg RE)
Number of subjects: 1431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1431
Study: 9245870

Group type: EXPERIMENTAL
Intervention: Teicoplanin administered to half the patients at the start of the procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study: 8506518

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3102754

Group type: EXPERIMENTAL
Intervention: TPN supplementation
Number of subjects: 28

Group type: COMPARATOR
Intervention: No TPN supplementation (Control)
Number of subjects: 28
Study: 31478756

Group type: EXPERIMENTAL
Intervention: Sexual arousal condition in Study 1
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Disgust condition in Study 2
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control condition in Study 1
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control condition in Study 2
Number of subjects: 290
Study: 30354397

Group type: EXPERIMENTAL
Intervention: Omega-3 therapy (4 mg/d for 310±87 days)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (observed for 302±102 days)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Omega-3 therapy
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study: 27406347

Group type: EXPERIMENTAL
Intervention: Veliparib-Carboplatin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control Therapy
Number of subjects: 72
Study: 24968280

Group type: EXPERIMENTAL
Intervention: Liquid protein snack containing 30 g carbohydrates and 30 g proteins (casein, whey protein or an equal mix of the two; n 26-28 per group)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Liquid protein snack (casein, whey protein or an equal mix)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Liquid protein snack
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control snack containing 60 g maltodextrin
Number of subjects: 82
Study: 22440090

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) augmented with information provision and behavioral skills building based on the IMB model
Number of subjects: 250
Study: 20505049

Group type: EXPERIMENTAL
Intervention: Resin infiltration (Icon, pre‐product; DMG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 22
Study: 20633375

Group type: EXPERIMENTAL
Intervention: Motor Cortex Stimulation (MCS) ON
Number of subjects: 10

Group type: COMPARATOR
Intervention: Motor Cortex Stimulation (MCS) OFF
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Motor Cortex Stimulation (MCS)
Number of subjects: 10
Study: 17253121

Group type: EXPERIMENTAL
Intervention: 2D and 3D intracardiac echocardiography (ICE)
Number of subjects: 32
Study: 12814458

Group type: EXPERIMENTAL
Intervention: Gliclazide 80 mg BID for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glimepiride 2 mg OD for 4 weeks
Number of subjects: 0
Study: 10812323

Group type: EXPERIMENTAL
Intervention: Persistent fasting hyperglycemia (PFH)
Number of subjects: 6346

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance (IGT)
Number of subjects: 6346

Group type: EXPERIMENTAL
Intervention: New diabetes
Number of subjects: 6346

Group type: EXPERIMENTAL
Intervention: Known diabetes
Number of subjects: 6346

Group type: COMPARATOR
Intervention: Normal glucose tolerance (NGT)
Number of subjects: 6346
Study: 8859194

Group type: EXPERIMENTAL
Intervention: Low dose leucovorin (20 mg/m2/day by intravenous bolus) and 5-fluorouracil (425-600 mg/m2/day for 5 consecutive days every 28 days)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Low dose leucovorin and 5-fluorouracil
Number of subjects: 25
Study: 1495798

Group type: EXPERIMENTAL
Intervention: 70 ng TGF-beta 2
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 330 ng TGF-beta 2
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1330 ng TGF-beta 2
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 70 ng TGF-beta 2 with hyaluronic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 330 ng TGF-beta 2 with hyaluronic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1330 ng TGF-beta 2 with hyaluronic acid
Number of subjects: 60
Study: 6538429

Group type: EXPERIMENTAL
Intervention: Flurazepam 45 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30118380

Group type: EXPERIMENTAL
Intervention: Optic nerve sheath diameter (ONSD) measurement using ultrasound
Number of subjects: 23
Study: 30012188

Group type: EXPERIMENTAL
Intervention: Collaborative care model including individualized self-care education prior to discharge and 6-month follow-up in community health service centers.
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Collaborative care model
Number of subjects: 135

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 135
Study: 27221799

Group type: EXPERIMENTAL
Intervention: Renin angiotensin blockade (RAB)
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Investigative angiograms
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Optimized medical therapy
Number of subjects: 872

Group type: EXPERIMENTAL
Intervention: Median time to death, end-stage kidney disease and cardiovascular events
Number of subjects: 872
Study: 24594851

Group type: EXPERIMENTAL
Intervention: Lake Hévíz thermal mineral water therapy (n = 38)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (tap water therapy, n = 39)
Number of subjects: 77
Study: 22248752

Group type: COMPARATOR
Intervention: Vasoactive drugs (dopamine + norepinephrine)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Vasoactive drugs (dopamine + norepinephrine + IABP therapy)
Number of subjects: 78
Study: 20870002

Group type: EXPERIMENTAL
Intervention: Sweet rice meal preload
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Savory rice meal preload
Number of subjects: 61
Study: 18615974

Group type: EXPERIMENTAL
Intervention: Telehealth follow-up care
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard care follow-up
Number of subjects: 106
Study: 16304304

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS) with continued training for 3 months postoperatively.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Physical training alone for 1 year (training group).
Number of subjects: 106
Study: 12038884

Group type: EXPERIMENTAL
Intervention: 6 mg/kg per day of enteral iron
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 12 mg/kg per day of enteral iron
Number of subjects: 64
Study: 10220203

Group type: EXPERIMENTAL
Intervention: Healthy offspring of parents with Type 1 DM and end-stage renal disease
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy offspring of parents with long duration Type 1 DM without nephropathy
Number of subjects: 12
Study: 8687301

Group type: EXPERIMENTAL
Intervention: Doppler method
Number of subjects: 130

Group type: COMPARATOR
Intervention: Non-Doppler method
Number of subjects: 130

Group type: COMPARATOR
Intervention: Non-Doppler method (junior staff)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Doppler method (rescue procedure)
Number of subjects: 130
Study: 2238351

Group type: EXPERIMENTAL
Intervention: Radiotherapy followed by surgery
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Surgery followed by radiotherapy
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Preventive removal of cervical fat
Number of subjects: 363

Group type: COMPARATOR
Intervention: Elective radiotherapy
Number of subjects: 363

Group type: COMPARATOR
Intervention: Only surgery
Number of subjects: 363

Group type: COMPARATOR
Intervention: Radical radiotherapy
Number of subjects: 363
Study: 21506

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sulfentanil
Number of subjects: 45
Study: 31551606

Group type: EXPERIMENTAL
Intervention: IV1 (loading dose 15 mg TXA/kg single intravenous administration)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IV2 (loading dose 15 mg TXA/kg + additional dose 15 mg TXA/kg 6 h after the first application)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: COMB (IV1 + local wash of 2 g of TXA in 50 mL of saline)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TOP (topical administration of 2 g of TXA in 50 mL of saline)
Number of subjects: 100

Group type: COMPARATOR
Intervention: IV1, IV2
Number of subjects: 100
Study: 30730251

Group type: EXPERIMENTAL
Intervention: Gender-transformative life skills education and sports-coaching programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 28719281

Group type: EXPERIMENTAL
Intervention: Handwashing with soap and water treatment intervention
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Observed handwashing with soap at food and stool-related events
Number of subjects: 320
Study: 25785967

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 524

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 524
Study: 23516412

Group type: EXPERIMENTAL
Intervention: Olive leaf extract (OLE) 51.1 mg oleuropein, 9.7 mg hydroxytyrosol per day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 21288278

Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 432

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 432
Study: 19233390

Group type: EXPERIMENTAL
Intervention: Pelvic floor electrical stimulation plus biofeedback (twice a week for 6 weeks, starting 7 days after catheter removal)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pelvic floor electrical stimulation plus biofeedback
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 17049132

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) with prior electrical stimulation over the cutaneous nerve of the left index finger
Number of subjects: 2

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 2
Study: 15116297

Group type: EXPERIMENTAL
Intervention: Valganciclovir
Number of subjects: 301

Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 301
Study: 11981112

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 13320

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 13320
Study: 9779365

Group type: EXPERIMENTAL
Intervention: Patients with gastroesophageal reflux (GER)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Patients with GER without esophagitis or erosive esophagitis
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Patients with short-segment Barrett's esophagus (BE)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Patients with long-segment Barrett's esophagus (BE)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Patients with GER
Number of subjects: 500
Study: 7819778

Group type: EXPERIMENTAL
Intervention: Laparoscopic oocyte aspiration
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ultrasound-guided oocyte aspiration
Number of subjects: 38
Study: 2449013

Group type: EXPERIMENTAL
Intervention: Topical clobetasol-17-propionate (CP)
Number of subjects: 0
Study: 29924393

Group type: EXPERIMENTAL
Intervention: Oral nutrition alone (n = 124 days, 55%)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oral nutrition in combination with enteral nutrition (n = 96 days, 42%)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Indirect calorimetry (n = 12 patients)
Number of subjects: 32
Study: 29191321

Group type: EXPERIMENTAL
Intervention: Abdominal obesity (waist circumference ≥102 cm in men and ≥88 cm in women)
Number of subjects: 3310

Group type: COMPARATOR
Intervention: No abdominal obesity
Number of subjects: 3310

Group type: EXPERIMENTAL
Intervention: Abdominal obesity
Number of subjects: 3310
Study: 26388465

Group type: EXPERIMENTAL
Intervention: Low-concentration protocol (240 mg I/mL, 80 kVp)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional protocol (350 mg I/mL, 120 kVp)
Number of subjects: 63
Study: 23496948

Group type: EXPERIMENTAL
Intervention: Guideline-based care by occupational physicians (innovative training to improve guideline adherence)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Guideline-based care by occupational physicians
Number of subjects: 232
Study: 21944654

Group type: EXPERIMENTAL
Intervention: Eurythmy therapy (EYT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study: 18083783

Group type: EXPERIMENTAL
Intervention: Detemir
Number of subjects: 10

Group type: COMPARATOR
Intervention: Human Insulin
Number of subjects: 10
Study: 16160708

Group type: EXPERIMENTAL
Intervention: Exogenous progesterone during the follicular phase in women
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo in men
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal follicular phase in women
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal luteal phase in women
Number of subjects: 21
Study: 12900684

Group type: EXPERIMENTAL
Intervention: 60 mg of pseudoephedrine hydrochloride (D)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 11
Study: 10865315

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (Hibiclens) cleaning
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no cleaning)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate cleaning with adenovirus serovar 5 inoculation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control with adenovirus serovar 5 inoculation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate cleaning with herpes simplex type 2 inoculation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control with herpes simplex type 2 inoculation
Number of subjects: 60
Study: 9354192

Group type: COMPARATOR
Intervention: mesalazine 500 mg t.d.s.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: oral preparation of viable E. coli strain Nissle (Serotype 06: K5: H1)
Number of subjects: 120
Study: 8449257

Group type: EXPERIMENTAL
Intervention: Active management with syntometrine and controlled cord traction
Number of subjects: 193

Group type: COMPARATOR
Intervention: Physiological management (cord not clamped, placenta delivered by maternal effort)
Number of subjects: 193
Study: 3761107

Group type: EXPERIMENTAL
Intervention: Fortified preterm human milk
Number of subjects: 30

Group type: COMPARATOR
Intervention: High-caloric-density premature formula
Number of subjects: 30

Group type: COMPARATOR
Intervention: Preterm human milk
Number of subjects: 30
Study: 30416909

Group type: EXPERIMENTAL
Intervention: CHAMP (behavioral family lifestyle intervention)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Health education attention control
Number of subjects: 24
Study: 27059306

Group type: EXPERIMENTAL
Intervention: Augmented prescribed exercise programme (APEP) - tailored strengthening and balance exercises
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sham group - stretching and relaxation exercises
Number of subjects: 220
Study: 25913341

Group type: EXPERIMENTAL
Intervention: Health literacy-focused intervention to promote cancer screenings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 23627775

Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 µg once daily
Number of subjects: 484

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 484
Study: 20883581

Group type: EXPERIMENTAL
Intervention: New Beginnings Program
Number of subjects: 240
Study: 18675402

Group type: EXPERIMENTAL
Intervention: Enhanced group (weekly moderated online chat sessions)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Minimal group (no additional chat sessions)
Number of subjects: 66
Study: 15667387

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12450905

Group type: EXPERIMENTAL
Intervention: 400 IU RRR-alpha-tocopherol/d
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10 mL CGJ.kg(‐1).d(‐1)
Number of subjects: 32
Study: 10622478

Group type: EXPERIMENTAL
Intervention: Medoff sliding plate (MSP)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Dynamic hip screw (DHS)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Dynamic condylar screw (DCS)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Dynamic hip screw with trochanteric stabilizing plate (DHS/TSP)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Comparison of MSP to other devices
Number of subjects: 107
Study: 7860750

Group type: EXPERIMENTAL
Intervention: Nondiabetic twins
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NIDDM twins
Number of subjects: 12

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 12
Study: 1974689

Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Formoterol 24 micrograms
Number of subjects: 16

Group type: COMPARATOR
Intervention: Salbutamol 200 micrograms
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7193004

Group type: EXPERIMENTAL
Intervention: Oral enzyme preparation of trypsin/chymotrypsin (Chymoral 100/F)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 32
Study: 31710967

Group type: EXPERIMENTAL
Intervention: Exposure to 4 °C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Exposure to 21 °C or 37 °C
Number of subjects: 20
Study: 29254495

Group type: EXPERIMENTAL
Intervention: 35% oxygen
Number of subjects: 100

Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 100
Study: 25380743

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic rectal surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional laparoscopic rectal surgery
Number of subjects: 40
Study: 24323698

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 869

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 869
Study: 23052635

Group type: EXPERIMENTAL
Intervention: Computer-navigated total knee arthroplasty
Number of subjects: 520

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 520
Study: 19714856

Group type: EXPERIMENTAL
Intervention: LGG and L. gasseri TMC0356 fermented milk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17729021

Group type: EXPERIMENTAL
Intervention: Duloxetine (30 or 60 mg daily for the first week, followed by 60, 90, or 120 mg daily for up to 11 weeks)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 249
Study: 11126205

Group type: COMPARATOR
Intervention: ZD2079
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: ZD7114
Number of subjects: 39
Study: 9110521

Group type: EXPERIMENTAL
Intervention: Capitated Integrated Service Agency (ISA) model
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care under the existing county service system
Number of subjects: 100
Study: 1550971

Group type: EXPERIMENTAL
Intervention: A gloves
Number of subjects: 1844

Group type: EXPERIMENTAL
Intervention: B gloves
Number of subjects: 1844

Group type: EXPERIMENTAL
Intervention: Surgeons
Number of subjects: 1844

Group type: EXPERIMENTAL
Intervention: Scrub nurses and assistants
Number of subjects: 1844
Study: 3887500

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (blood pressure monitoring, weight checks, health counseling)
Number of subjects: 22
Study: 30145600

Group type: EXPERIMENTAL
Intervention: Trocar-site infiltration with lidocaine (n = 100)
Number of subjects: 199

Group type: COMPARATOR
Intervention: No intervention (n = 99)
Number of subjects: 199
Study: 27657351

Group type: EXPERIMENTAL
Intervention: Social intervention (GoodMood) including supervised exercise, social activity, or personal counseling
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 223
Study: 27580078

Group type: EXPERIMENTAL
Intervention: Clock-turn strategy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Usual-turn
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dual task
Number of subjects: 25
Study: 25542687

Group type: EXPERIMENTAL
Intervention: Tetrahydrocannabivarin (10mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20